Table 5.

Incontinence aid usage by participants in the treatment group (n=60) and information group (n=63), reported at baseline and at follow-up.

Allocation and incontinence aid usage		Participants, n (%)		P value
		Baseline	Follow-up	Within-group comparisona		Between-group comparison at follow-upb
Treatment app					<.001	.01
	Never	11 (18.3)	26 (43.3)c
	<1/week	10 (16.7)	12 (20)
	1-3/week	12 (20)	4 (6.7)
	>3/week, not daily	4 (6.7)	2 (3.3)
	1/day	12 (20.0)	10 (16.7)
	>1/day	11 (18.3)	6 (10)c
Information app					.15
	Never	14 (22.2)	14 (22.2)
	<1/week	11 (17.5)	11 (17.5)
	1-3/week	7 (11.1)	8 (12.7)
	>3/week, not daily	4 (6.3)	6 (9.5)
	1/day	11 (17.5)	13 (20.6)
	>1/day	16 (25.4)	11 (17.5)

^aWilcoxon signed-rank test.

^bMann-Whitney U test.

^cImputed baseline value for 1 participant lost to follow-up.